1-155240033-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_001171811.2(GBA1):c.-102G>A variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.000000684 in 1,461,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001171811.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBA1 | NM_000157.4 | c.160G>A | p.Val54Met | missense_variant | Exon 3 of 11 | ENST00000368373.8 | NP_000148.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461826Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727206
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Gaucher disease type I Pathogenic:1
The c.160G>A variant in the GBA gene has been previously detected in multiple patients from at least 5 independent families with Gaucher disease in homozygous or compound heterozygous state (PMID: 11783951, 14757438, 22429443, 33301762) (PM3_strong) and functional studies have shown that the variant impairs the activity (PMID: 14757438, 33301762) (PS3). Additionally, the variant has an extremely low presence in gnomAD 4.1 (AF= 6.196e-7) (PM2). With all the available evidence, the variant is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.